1. Shapiro EL, inventor; Schering-Plough Corporation, assignee. 3,20-Dioxo-1,4-diene-17α-ol 17-aromatic heterocycle carboxylates. US Patent 4 472 393. 1984 Sept. 18.
2. A clinical investigation of the efficacy and safety of mometasone furoate ointment 0.1% versus betamethasone valerate ointment 0.1% in the treatment of psoriasis;Rosenthal;Curr Ther Res,1988
3. Once-daily 0.1% mometasone furoate cream versus twice daily 0.1% betamethasone valerate cream in the treatment of a variety of dermatoses;Viglioglia;J Int Med Res,1990
4. Mometasone furoate ointment and cream 0.1 percent in treatment of psoriasis;Medansky;Cutis,1988
5. Comparison of the effect of mometasone furoate ointment 0.1% and hydrocortisone ointment 1.0%, on adrenocorticoid function in psoriasis patients;Bressinck;Today Ther Trends,1988